| Uniprot ID: | P01137 |
| Secondary ID: | A8K792, Q9UCG4 |
| Symbol: | TGFB1 |
| Other Name: | TGFB,Latency-associated peptide,Transforming growth factor beta-1,LAP,TGF-beta-1 |
| Class: | Single Protein |
| Type: | pro-fibrotic |
| Molecular Function: | Growth factor,Mitogen |
| Category I | Category II | Category III |
|---|---|---|
| Extracellular | Growth factor and receptor | TGF-beta superfamily |
| Target ID | Name | Interaction |
|---|---|---|
| D0922 | TGF-b + FnEDA DVD-Ig | inhibitor |
| D0931 | 1D11 | antagonist |
| D0934 | Anti-TGFβ antibody | inhibitor |
| D0989 | p17 | antagonist |
Reference Record 1
Reference Record 2
| PubMed ID | 27864286 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
Reference Record 4
Reference Record 5
| PubMed ID | 24338442 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | |||
| Mechanism | |||
Reference Record 6
| PubMed ID | 24282226 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Corneal fibrosis |
| Process I | |||
| Process II | fibroblasts migration | ||
| Process III | |||
| Mechanism | |||
Reference Record 7
| PubMed ID | 22558184 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 8
| PubMed ID | 22277325 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Bladder fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 9
| PubMed ID | 22033267 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 10
| PubMed ID | 21600192 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 11
| PubMed ID | 21320502 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 12
| PubMed ID | 21195468 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Smad3 and Smad7 | ||
Reference Record 13
| PubMed ID | 19734317 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 14
| PubMed ID | 19641518 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β/Smad/CTGF | ||
Reference Record 15
| PubMed ID | 19502172 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | fibroblasts activation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 16
| PubMed ID | 19374154 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Vocal fold fibrosis |
| Process I | |||
| Process II | cells migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 17
| PubMed ID | 16443218 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 18
| PubMed ID | 16036560 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 19
| PubMed ID | 15782092 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Pancreatic fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 20
| PubMed ID | 15194465 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | myofibroblasts differentiation | ||
| Process III | |||
| Mechanism | Targeting ro-MT1-MMP and pro-MMP-2 | ||
Reference Record 21
| PubMed ID | 15117744 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 22
| PubMed ID | 14565855 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 23
| PubMed ID | 12114216 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 24
| PubMed ID | 17947678 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Subpleural fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 25
Reference Record 26
| PubMed ID | 11438473 | Compound ID | |
| CAS | Name | ||
| Model | vitro,pig | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | cells proliferation | ||
| Process III | |||
| Mechanism | Targeting Smad2 and Smad3 | ||
Reference Record 27
| PubMed ID | 11413354 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 28
| PubMed ID | 11073825 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Keloid |
| Process I | |||
| Process II | cells apoptosis | ||
| Process III | |||
| Mechanism | |||
Reference Record 29
| PubMed ID | 28932540 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||